 "Sanofi invests Rs 90 cr in Apollo Sugar Clinics")
Apollo Health and Lifestyle Ltd, a wholly-owned subsidiary of Apollo Hospitals Enterprise Ltd, has announced that Sanofi-Synthelabo India Ltd has invested into Apollo Sugar Clinics Ltd (ASCL) - a single specialty business focused on providing high quality, integrated care across its clinics for people with diabetes.
Sanofi-Synthelabo India, a part of pharma major Sanofi group, will invest Rs 90 crore in ASCL through a combination of primary and secondary funding.
Through this investment, both Apollo and Sanofi would endeavour to expand Apollo Sugar Clinics to provide superior value to patients and doctors with an enhanced geographic reach, and provide high quality outcome oriented set of services.
Dr Prathap Reddy, chairman and founder, Apollo Hospitals Group, said, "I am confident that with this investment, Apollo Sugar Clinics is even better positioned to offer patients advanced care and counselling for diabetes management. I am delighted to be partnering with Sanofi, a global leader in diabetes management."
Sanofi-Synthelabo India, a part of pharma major Sanofi group, will invest Rs 90 crore in ASCL through a combination of primary and secondary funding.
Through this investment, both Apollo and Sanofi would endeavour to expand Apollo Sugar Clinics to provide superior value to patients and doctors with an enhanced geographic reach, and provide high quality outcome oriented set of services.
Dr Prathap Reddy, chairman and founder, Apollo Hospitals Group, said, "I am confident that with this investment, Apollo Sugar Clinics is even better positioned to offer patients advanced care and counselling for diabetes management. I am delighted to be partnering with Sanofi, a global leader in diabetes management."